MedQuist (MEDQ) has recently been recommended at one of our small cap Boston idea forums. This leading provider of medical transcription technology and services has announced a successful resolution of long-standing SEC and DOJ investigations and has settled class action lawsuits. MEDQ has most of the major US hospital systems under contract and is well-positioned to benefit from proliferation of electronic health records and the need to adopt existing systems to the new standard. The stock is trading at a significant discount to free cash flow and can potentially more than double from the current level.